West Pharmaceutical Services, Inc. (BVMF:W2ST34)

BVMF:W2ST34 Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	93,483	146,722	126,418	92,112	193,584	108,768
Market Cap Growth	-36.60%	16.06%	37.24%	-52.42%	77.98%	143.27%
Enterprise Value	91,784	145,590	123,547	89,843	191,509	107,782
Last Close Price	34.50	56.06	48.83	37.17	74.33	-
PE Ratio	35.67	48.15	43.91	29.74	52.50	60.50
PS Ratio	5.81	8.20	8.83	6.04	12.27	9.76
PB Ratio	5.75	8.84	9.04	6.49	14.88	11.29
P/TBV Ratio	5.98	9.25	9.45	6.81	15.78	12.23
P/FCF Ratio	46.27	85.83	62.86	39.65	105.09	70.26
P/OCF Ratio	25.28	36.31	33.55	24.07	59.49	44.33
EV/Sales Ratio	5.83	8.14	8.63	5.89	12.14	9.67
EV/EBITDA Ratio	20.58	31.43	30.19	19.22	38.58	39.03
EV/EBIT Ratio	27.10	39.66	36.05	22.25	44.72	49.11
EV/FCF Ratio	45.43	85.17	61.43	38.68	103.97	69.62
Debt / Equity Ratio	0.10	0.11	0.11	0.12	0.14	0.18
Debt / EBITDA Ratio	0.36	0.39	0.35	0.35	0.36	0.60
Debt / FCF Ratio	0.80	1.11	0.75	0.72	0.98	1.11
Asset Turnover	0.78	0.77	0.79	0.83	0.93	0.84
Inventory Turnover	4.63	4.67	4.28	4.41	4.73	4.95
Quick Ratio	2.02	1.93	2.07	2.73	2.13	1.99
Current Ratio	2.87	2.80	2.88	3.70	2.93	2.73
Return on Equity (ROE)	16.95%	17.71%	21.32%	23.34%	31.59%	20.20%
Return on Assets (ROA)	10.22%	9.93%	11.86%	13.78%	15.73%	10.29%
Return on Invested Capital (ROIC)	18.60%	20.14%	26.35%	31.89%	38.14%	23.03%
Return on Capital Employed (ROCE)	18.30%	19.20%	22.40%	24.70%	28.30%	18.50%
Earnings Yield	2.80%	2.08%	2.28%	3.36%	1.91%	1.65%
FCF Yield	2.16%	1.17%	1.59%	2.52%	0.95%	1.42%
Dividend Yield	0.27%	8.94%	7.65%	10.38%	5.17%	-
Payout Ratio	12.34%	12.00%	9.61%	9.23%	7.72%	13.89%
Buyback Yield / Dilution	1.55%	2.13%	0.66%	0.66%	-0.66%	-0.53%
Total Shareholder Return	1.82%	11.06%	8.31%	11.04%	4.51%	-0.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.